ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "T cell graft infiltration"

  • 2016 American Transplant Congress

    Acute Rejection in Non-Human Primates Treated with Belatacept Is Mediated by a Unique CD8 Memory Subset.

    D. Mathews,1 W. Wakwe,1 M. Lowe,1 C. Breeden,1 F. Leopardi,1 A. Farris,1 M. Song,1 E. Strobert,2 J. Jenkins,2 C. Larsen,1 R. Townsend,3 A. Adams.1

    1Emory Transplant Center, Emory University, Atlanta, GA; 2Yerkes National Primate Research Center, Atlanta, GA; 3Bristol Myers-Squibb Pharmaceutical Research Institute, Princeton, NJ.

    Belatacept is a high affinity version of the fusion protein CTLA4-Ig that blocks CD28 mediated T cell costimulation, providing a more targeted/less toxic form of…
  • 2016 American Transplant Congress

    Peritransplant Costimulation Blockade Combined with a Short-Course of Rapamycin Prevents Rejection of Vascularized Composite Allografts.

    B. Oh, G. Furtmüller, M. Fryer, P. Akre, D. Cooney, W. Lee, G. Raimondi, G. Brandacher.

    Department of Plastic and Reconstructive Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.

    [Background] Reconstructive transplantation represents a valid therapeutic option after devastating tissue loss. Routine clinical application, however, is hampered by the toxicity of long-term maintenance immunosuppression.…
  • 2015 American Transplant Congress

    VLA-4 Blockade Inhibits Endogenous Memory CD8 T Cell-Mediated Rejection of Cardiac Allografts

    S. Iida,1 C. Su,1 T. Abe,1 K. Tanabe,2 R. Fairchild.1

    1Immunology, Cleveland Clinic, Cleveland, OH; 2Urology, Tokyo Women's Medical University, Tokyo, Japan.

    Endogenous memory CD8 T cells infiltrate cardiac allografts within 24 hours of reperfusion and are activated to proliferate and produce IFN-γ in response to donor…
  • 2015 American Transplant Congress

    Allograft Class II MHC and CD40 Expression Are Required for Endogenous Memory CD8 T Cell Proliferation in Cardiac Allografts Subjected to Prolonged Cold Ischemic Storage

    T. Tanaka,1,2 H. Tsuda,1,3 N. Kohei,1,4 D. Kish,1 W. Baldwin,1 A. Valujskikh,1 R. Fairchild.1

    1Immunology, Cleveland Clinic, Cleveland, OH; 2Urology, Sapporo Medical University, Sapporo, Japan; 3Urology, Osaka University, Osaka, Japan; 4Urology, Kidney Center, Tokyo Women's Medical University, Tokyo, Japan.

    Endogenous memory CD8 T cells infiltrate MHC-mismatched cardiac allografts and produce IFN-γ in response to donor class І MHC within 24 hrs after graft reperfusion…
  • 2015 American Transplant Congress

    CD4 T Cell Mediated Help Is Required for Endogenous Memory CD8 T Cell Proliferation in Cardiac Allografts Subjected to Prolonged Cold Ischemic Storage

    H. Tsuda,1,4 T. Tanaka,2,4 N. Kohei,3,4 D. Kish,4 W. Baldwin,4 A. Valujskikh,4 R. Fairchild.4

    1Advanced Technology for Transplantation, Osaka Univ., Suita, Japan; 2Urology, Sapporo Medical Univ., Sapporo, Japan; 3Urology, Tokyo Women's Medical Univ., Tokyo, Japan; 4Immunology, Cleveland Clinic, Cleveland, OH.

    Endogenous memory CD8 T cells infiltrate MHC-mismatched cardiac allografts and produce IFN-γ in response to donor class І MHC within 24 hrs after graft reperfusion…
  • 2015 American Transplant Congress

    Aquaporin 4 Blockade Is a Novel Strategy Targeting Ischemia/Reperfusion Injury in Heart Transplantation

    K. Ayasoufi,1 N. Kohei,1 G. Farr,2 P. McGuirk,2 M. Pelletier,2 R. Fairchild,1 A. Valujskikh.1

    1Immunology, Cleveland Clinic, Cleveland, OH; 2Aeromics, LLC, Cleveland, OH.

    Aquaporin 4 (AQP4) belongs to the family of small integrin transmembrane proteins that are highly permeable to water. It was recently shown that human and…
  • 2015 American Transplant Congress

    IL-21 Regulates Creation of Tertiary Lymphoid Organs in Chronic Allograft Rejection

    C. Baum,1 M. Khattar,2 P. Schroder,1 W. Chen,3 S. Stepkowski.1

    1Medical Microbiology and Immunology, University of Toledo College of Medicine, Toledo, OH; 2Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, MA; 3Transplant Immunology Research Program, Houston Methodist Research Institute, Houston, TX.

    BACKGROUND: IL-21 is a cytokine expressed almost exclusively by cells of the adaptive immune system. This makes it an attractive target for reducing chronic allograft…
  • 2015 American Transplant Congress

    CD3+CD4+ROR gamma t+ TH17 Cells Do Not Play a Critical Role in Islet Allograft Rejection

    M. Koulmanda, Z. Fan.

    Medicine, The Transplant Institute, Beth Israel Deaconess Medical Center, Boston, MA.

    We have developed a “color-coded” adoptive transfer model for T cell subset identification that enables serial analysis of islet allograft infiltrating yellow induced regulatory T…
  • 2015 American Transplant Congress

    Effector T Cell Migration to Pancreatic Islet Allografts Is Dependent On Donor Antigen Recognition and Not Gαi Chemokine Signaling

    Q. Zhang, H. Dai, Q. Zeng, A. Williams, M. Oberbarnscheidt, F. Lakkis.

    Thomas E. Starzl Transplantation Institute, UPMC, Pittsburgh, PA.

    Infiltration of the graft with host effector T cells after transplantation is a key step in the pathogenesis of both acute and chronic rejection. Recent…
  • 2015 American Transplant Congress

    Immunological Aspects of Iron Overload in Heart and Kidney Transplantation

    T. Resch,1 S. Ebner,1 P. Ritschl,1 M. Ashraf,1 C. Fabritius,1 A. Brunner,2 V. Nguyen,1 J. Günther,1 J. Pratschke,3 K. Kotsch.1

    1Department of Surgery, Medical University Innsbruck, Innsbruck, Austria; 2Department of Pathology, Medical University Innsbruck, Innsbruck, Austria; 3Department of Surgery, Charité, Berlin, Germany.

    Background: Clinical data suggest that iron (Fe) overload deleteriously affects graft survival after heart (HTX) and kidney transplantation (KTX) but possible immunologic mechanisms underlying this…
  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences